Cargando…

FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD

INTRODUCTION: A better understanding is needed of the different phenotypes that exist for patients with chronic obstructive pulmonary disease (COPD), their relationship with the pathogenesis of COPD and how they may affect disease progression. Biomarkers, including those associated with emphysema, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Crapo, James, Gupta, Abhya, Lynch, David A, Vogel-Claussen, Jens, Watz, Henrik, Turner, Alice M, Mroz, Robert M, Janssens, Wim, Ludwig-Sengpiel, Andrea, Beck, Markus, Langellier, Bérengère, Ittrich, Carina, Risse, Frank, Diefenbach, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986686/
https://www.ncbi.nlm.nih.gov/pubmed/33753437
http://dx.doi.org/10.1136/bmjopen-2020-042526
_version_ 1783668490812522496
author Crapo, James
Gupta, Abhya
Lynch, David A
Vogel-Claussen, Jens
Watz, Henrik
Turner, Alice M
Mroz, Robert M
Janssens, Wim
Ludwig-Sengpiel, Andrea
Beck, Markus
Langellier, Bérengère
Ittrich, Carina
Risse, Frank
Diefenbach, Claudia
author_facet Crapo, James
Gupta, Abhya
Lynch, David A
Vogel-Claussen, Jens
Watz, Henrik
Turner, Alice M
Mroz, Robert M
Janssens, Wim
Ludwig-Sengpiel, Andrea
Beck, Markus
Langellier, Bérengère
Ittrich, Carina
Risse, Frank
Diefenbach, Claudia
author_sort Crapo, James
collection PubMed
description INTRODUCTION: A better understanding is needed of the different phenotypes that exist for patients with chronic obstructive pulmonary disease (COPD), their relationship with the pathogenesis of COPD and how they may affect disease progression. Biomarkers, including those associated with emphysema, may assist in characterising patients and in predicting and monitoring the course of disease. The FOOTPRINTS study (study 352.2069) aims to identify biomarkers associated with emphysema, over a 3-year period. METHODS AND ANALYSIS: The FOOTPRINTS study is a prospective, longitudinal, multinational (12 countries), multicentre (51 sites) biomarker study, which has enrolled a total of 463 ex-smokers, including subjects without airflow limitation (as defined by the 2015 Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy report), patients with COPD across the GOLD stages 1–3 and patients with COPD and alpha1-antitrypsin deficiency. The study has an observational period lasting 156 weeks that includes seven site visits and additional phone interviews. Biomarkers in blood and sputum, imaging data (CT and magnetic resonance), clinical parameters, medical events of special interest and safety are being assessed at regular visits. Disease progression based on biomarker values and COPD phenotypes are being assessed using multivariate statistical prediction models. ETHICS AND DISSEMINATION: The study protocol was approved by the authorities and ethics committees/institutional review boards of the respective institutions where applicable, which included study sites in Belgium, Canada, Denmark, Finland, Germany, Japan, Korea, Poland, Spain, Sweden, UK and USA; written informed consent has been obtained from all study participants. Ethics committee approval was obtained for all participating sites prior to enrolment of the study participants. The study results will be reported in peer-reviewed publications. TRIAL REGISTRATION NUMBER: NCT02719184.
format Online
Article
Text
id pubmed-7986686
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-79866862021-03-29 FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD Crapo, James Gupta, Abhya Lynch, David A Vogel-Claussen, Jens Watz, Henrik Turner, Alice M Mroz, Robert M Janssens, Wim Ludwig-Sengpiel, Andrea Beck, Markus Langellier, Bérengère Ittrich, Carina Risse, Frank Diefenbach, Claudia BMJ Open Respiratory Medicine INTRODUCTION: A better understanding is needed of the different phenotypes that exist for patients with chronic obstructive pulmonary disease (COPD), their relationship with the pathogenesis of COPD and how they may affect disease progression. Biomarkers, including those associated with emphysema, may assist in characterising patients and in predicting and monitoring the course of disease. The FOOTPRINTS study (study 352.2069) aims to identify biomarkers associated with emphysema, over a 3-year period. METHODS AND ANALYSIS: The FOOTPRINTS study is a prospective, longitudinal, multinational (12 countries), multicentre (51 sites) biomarker study, which has enrolled a total of 463 ex-smokers, including subjects without airflow limitation (as defined by the 2015 Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy report), patients with COPD across the GOLD stages 1–3 and patients with COPD and alpha1-antitrypsin deficiency. The study has an observational period lasting 156 weeks that includes seven site visits and additional phone interviews. Biomarkers in blood and sputum, imaging data (CT and magnetic resonance), clinical parameters, medical events of special interest and safety are being assessed at regular visits. Disease progression based on biomarker values and COPD phenotypes are being assessed using multivariate statistical prediction models. ETHICS AND DISSEMINATION: The study protocol was approved by the authorities and ethics committees/institutional review boards of the respective institutions where applicable, which included study sites in Belgium, Canada, Denmark, Finland, Germany, Japan, Korea, Poland, Spain, Sweden, UK and USA; written informed consent has been obtained from all study participants. Ethics committee approval was obtained for all participating sites prior to enrolment of the study participants. The study results will be reported in peer-reviewed publications. TRIAL REGISTRATION NUMBER: NCT02719184. BMJ Publishing Group 2021-03-22 /pmc/articles/PMC7986686/ /pubmed/33753437 http://dx.doi.org/10.1136/bmjopen-2020-042526 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Respiratory Medicine
Crapo, James
Gupta, Abhya
Lynch, David A
Vogel-Claussen, Jens
Watz, Henrik
Turner, Alice M
Mroz, Robert M
Janssens, Wim
Ludwig-Sengpiel, Andrea
Beck, Markus
Langellier, Bérengère
Ittrich, Carina
Risse, Frank
Diefenbach, Claudia
FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD
title FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD
title_full FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD
title_fullStr FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD
title_full_unstemmed FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD
title_short FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD
title_sort footprints study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with copd
topic Respiratory Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986686/
https://www.ncbi.nlm.nih.gov/pubmed/33753437
http://dx.doi.org/10.1136/bmjopen-2020-042526
work_keys_str_mv AT crapojames footprintsstudyprotocolrationaleandmethodologyofa3yearlongitudinalobservationalstudytophenotypepatientswithcopd
AT guptaabhya footprintsstudyprotocolrationaleandmethodologyofa3yearlongitudinalobservationalstudytophenotypepatientswithcopd
AT lynchdavida footprintsstudyprotocolrationaleandmethodologyofa3yearlongitudinalobservationalstudytophenotypepatientswithcopd
AT vogelclaussenjens footprintsstudyprotocolrationaleandmethodologyofa3yearlongitudinalobservationalstudytophenotypepatientswithcopd
AT watzhenrik footprintsstudyprotocolrationaleandmethodologyofa3yearlongitudinalobservationalstudytophenotypepatientswithcopd
AT turneralicem footprintsstudyprotocolrationaleandmethodologyofa3yearlongitudinalobservationalstudytophenotypepatientswithcopd
AT mrozrobertm footprintsstudyprotocolrationaleandmethodologyofa3yearlongitudinalobservationalstudytophenotypepatientswithcopd
AT janssenswim footprintsstudyprotocolrationaleandmethodologyofa3yearlongitudinalobservationalstudytophenotypepatientswithcopd
AT ludwigsengpielandrea footprintsstudyprotocolrationaleandmethodologyofa3yearlongitudinalobservationalstudytophenotypepatientswithcopd
AT beckmarkus footprintsstudyprotocolrationaleandmethodologyofa3yearlongitudinalobservationalstudytophenotypepatientswithcopd
AT langellierberengere footprintsstudyprotocolrationaleandmethodologyofa3yearlongitudinalobservationalstudytophenotypepatientswithcopd
AT ittrichcarina footprintsstudyprotocolrationaleandmethodologyofa3yearlongitudinalobservationalstudytophenotypepatientswithcopd
AT rissefrank footprintsstudyprotocolrationaleandmethodologyofa3yearlongitudinalobservationalstudytophenotypepatientswithcopd
AT diefenbachclaudia footprintsstudyprotocolrationaleandmethodologyofa3yearlongitudinalobservationalstudytophenotypepatientswithcopd